- Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News
- At JP Morgan, Affy Provides Update on Cyto FDA Submission, New Genotyping Products, Restructuring
January 15, 2013 / BioArray News
- Analysts, Investors 'Troubled' as Affymetrix's Preliminary Q3 Revenues Miss Estimates
October 9, 2012 / BioArray News
- Analysts Say Affy Turnaround 'Remains on Track' after Firm Posts 3 Percent Rise in Q2 Revenues
August 7, 2012 / BioArray News
- As Affymetrix Tries to Salvage Deal, eBioscience Explores Other Options
February 29, 2012 / GenomeWeb Daily News